Intra-Cellular Therapies Inc (ITCI)
131.87
0.00 (0.00%)
USD |
NASDAQ |
Apr 02, 16:00
Intra-Cellular Therapies Price to Book Value: 12.21 for April 2, 2025
View 4,000+ Financial Data Types:
Add
Browse
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 5.387 |
| Moderna Inc | 0.9120 |
| Eli Lilly and Co | 49.93 |
| AbbVie Inc | 106.99 |
| Sage Therapeutics Inc | 0.9755 |
Price to Book Value Related Metrics
| PS Ratio | 19.98 |
| Price | 131.87 |
| Earnings Yield | -0.55% |
| Market Cap | 14.02B |